» Authors » Hongtao Hu

Hongtao Hu

Explore the profile of Hongtao Hu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 393
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wen X, Lin H, Liu G, Ning Y, Xu X, Hu H, et al.
Food Res Int . 2025 Mar; 207:116109. PMID: 40086967
Whey powder (WP), a dairy by-product with high biochemical oxygen demand (BOD) and chemical oxygen demand (COD), presents challenges due to its high production, low-value utilization, and environmental pollution. Based...
2.
Wen X, Tesfay M, Ning Y, Lin H, Liu G, Hu H, et al.
Food Res Int . 2025 Mar; 206:116058. PMID: 40058916
Rare sugars are paid more attention because of which have the characteristics of low calorie, low absorption and excellent physiological functions. Biotechnological synthesis of rare sugars has the advantages of...
3.
Wang J, Wang Y, Zhang S, Hu H, Zhang R, Zi C, et al.
BMC Pharmacol Toxicol . 2025 Feb; 26(1):48. PMID: 40022263
Background: Triple-negative breast cancer is a clinically aggressive malignancy with poorer outcomes versus other subtypes of breast cancer. Numerous reports have discussed the use of epigallocatechin-3-gallate (EGCG) against various types...
4.
He X, Li Y, Han D, Zhou Y, Zhang J, Xu Q, et al.
Quant Imaging Med Surg . 2024 Dec; 14(12):8520-8537. PMID: 39698720
Background: Given the limited capacity and suboptimal sensitivity of ultrasonography (US), gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) demonstrates good diagnostic performance for hepatocellular carcinoma (HCC). Some researchers have...
5.
Zhao Y, Wu D, Yao Q, Yuan H, Hu H, Li H
Cent Eur J Immunol . 2024 Oct; 49(2):147-154. PMID: 39381555
Introduction: To explore the progression patterns of advanced hepatocellular carcinoma (HCC) in patients treated with a combination of local therapies, targeted drugs, and PD-1/PD-L1 inhibitors. Material And Methods: A retrospective...
6.
Jiang C, Shen C, Ni M, Huang L, Hu H, Dai Q, et al.
Genes Dis . 2024 Sep; 11(6):101063. PMID: 39224110
Ovarian cancer is one of the most common malignant tumors of the female reproductive system. The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy. As...
7.
Liu B, Ye X, Fan W, Zhi X, Ma H, Wang J, et al.
J Cancer Res Ther . 2024 Aug; 20(4):1109-1123. PMID: 39206972
This expert consensus reviews current literature and provides clinical practice guidelines for the diagnosis and treatment of multiple ground glass nodule-like lung cancer. The main contents of this review include...
8.
Hong W, Zeng X, Wang H, Tan X, Tian Y, Hu H, et al.
Pharmacol Res . 2024 May; 205:107228. PMID: 38810904
Coronavirus disease 2019 (COVID-19) affected people worldwide, and fever is one of the major symptoms of this disease. Although Acetaminophen (APAP) is a common fever-reducing medication, it can also mediate...
9.
Huang L, Wei Y, Ni M, Hu H, Xi L, Wang C, et al.
Molecules . 2024 Apr; 29(8). PMID: 38675657
Triple-negative breast cancer (TNBC) is a malignant breast cancer. There is an urgent need for effective drugs to be developed for TNBC. () has been reported to have an anti-tumor...
10.
Wang J, Zhang H, Hu H, Hu S, Ma L
Int J Biol Macromol . 2024 Apr; 268(Pt 1):131582. PMID: 38631589
Matrix metalloproteinase 9 (MMP-9) plays an important role in wound healing. However, overexpression of MMP-9 leads to the degradation of the newly formed extracellular matrix, which delays wound healing, ultimately...